Live Breaking News & Updates on Higher Dose Levels

Stay updated with breaking news from Higher dose levels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Anokion SA: Anokion Announces New Clinical Data from the Phase 1b/2 ACeD-it Trial Supporting KAN-101 as a Potential Disease-Modifying Treatment for Celiac Disease

Two Global Phase 2 Clinical Trials, the Phase 2 portion of ACeD-it and Phase 2a SynCeD Studies, are Ongoing in Individuals with Celiac Disease New Data Presented During Digestive Disease Week® 2024 ....

Switzerland , Swiss , Chris-brinzey , Deborah-geraghty , Two-global-phase , Synced-studies , Data-presented-during-digestive-disease-week , Potential-treatment , Immune-tolerance , Higher-dose-levels , Novel-immune-tolerance-therapy